Evidence map›Paper›PMID 37519525›Full record

ArticleCureus2023

Methicillin-Resistant Staphylococcus aureus (MRSA) Empyema Post-COVID Infection Causing Severe Septic Shock and Multiorgan Failure.

Antony Arumairaj, Ali Safavi, Hossam Amin, Armeen Poor, Natoushka Trenard

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Inhibition of Shikimate Kinase from Methicillin-ResistantInternational journal of molecular sciences · 2024
    Article
  3. Article
  4. Neonatal methicillin-resistantWorld journal of clinical cases · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Antony ArumairajInternal Medicine, Metropolitan Hospital Center/New York Medical College, New York City, USA.
Ali SafaviSurgery, Division of Thoracic Surgery, Metropolitan Hospital Center/New York Medical College, New York City, USA.
Hossam AminInternal Medicine/Division of Pulmonary Critical Care Medicine, Metropolitan Hospital Center/New York Medical College, New York City, USA.
Armeen PoorInternal Medicine/Division of Pulmonary Critical Care Medicine, Metropolitan Hospital Center/New York Medical College, New York City, USA.
Natoushka TrenardInternal Medicine/Division of Pulmonary Critical Care Medicine, Metropolitan Hospital Center/New York Medical College, New York City, USA.
Metropolitan Hospital Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Secondary bacterial infections post-COVID infection posed a major challenge to the healthcare settings during the COVID pandemic. We present the case of an 81-year-old patient who was initially admitted for COVID pneumonia in a tertiary care hospital and was managed with a course of dexamethasone and had a good outcome. However, post-discharge, the patient developed symptoms of productive cough, hemoptysis and shortness of breath. Evaluation of the patient revealed that the patient had developed a secondary bacterial infection with Methicillin-resistant

Indexed as

ardscovid 19empyemamrsamultifocal pneumoniamultiorgan failureseptic shock

Identifiers

PMID37519525
PMCPMC10374408
OpenAlexW4382196268

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.